Suppr超能文献

腺嘌呤磷酸核糖基转移酶缺乏症:早期诊断的必要性。

APRT deficiency: the need for early diagnosis.

作者信息

Huq Aamira, Nand Kushma, Juneja Rajiv, Winship Ingrid

机构信息

Department of Genomic Medicine, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Department of Nephrology, Western Health, Footscray, Australia.

出版信息

BMJ Case Rep. 2018 Oct 23;2018:bcr-2018-225742. doi: 10.1136/bcr-2018-225742.

Abstract

Adenine phosphoribosyltransferase (APRT) deficiency is a rare autosomal recessive disorder which leads to accumulation of poorly soluble 2,8-dihydroxyadenine in kidneys resulting in nephrolithiasis as well as chronic kidney disease from crystal nephropathy. This report describes a 55-year-old previously fit man who presented with shortness of breath and the investigative pathway that eventually led to a diagnosis of APRT deficiency. Early diagnosis has aided in timely institution of allopurinol, thereby improving his renal function and possibility of weaning off renal replacement therapy. Genetic testing has enabled early identification of other family members at risk and prevention of renal failure by commencing xanthine oxidoreductase (XOR) inhibitors. The issues surrounding kidney donation by a member of this family are also discussed. This case represents the importance of awareness and recognition of the signs and symptoms of this rare condition, complications of which can be easily prevented by early institution of XOR inhibitor therapy.

摘要

腺嘌呤磷酸核糖转移酶(APRT)缺乏症是一种罕见的常染色体隐性疾病,可导致难溶性2,8 - 二羟基腺嘌呤在肾脏中积聚,从而引发肾结石以及由晶体肾病导致的慢性肾病。本报告描述了一名55岁、既往健康的男性,他因呼吸急促就诊,其检查过程最终确诊为APRT缺乏症。早期诊断有助于及时使用别嘌醇,从而改善其肾功能,并有可能停用肾脏替代治疗。基因检测能够早期识别其他有风险的家庭成员,并通过开始使用黄嘌呤氧化还原酶(XOR)抑制剂预防肾衰竭。本文还讨论了该家族一名成员进行肾脏捐献的相关问题。该病例体现了认识和识别这种罕见疾病的体征和症状的重要性,通过早期使用XOR抑制剂治疗,其并发症很容易得到预防。

相似文献

1
APRT deficiency: the need for early diagnosis.
BMJ Case Rep. 2018 Oct 23;2018:bcr-2018-225742. doi: 10.1136/bcr-2018-225742.
2
Adenine phosphoribosyltransferase deficiency.
Clin J Am Soc Nephrol. 2012 Sep;7(9):1521-7. doi: 10.2215/CJN.02320312. Epub 2012 Jun 14.
3
Kidney Transplant Outcomes in Patients With Adenine Phosphoribosyltransferase Deficiency.
Transplantation. 2020 Oct;104(10):2120-2128. doi: 10.1097/TP.0000000000003088.
4
Adenine phosphoribosyltransferase deficiency in children.
Pediatr Nephrol. 2012 Apr;27(4):571-9. doi: 10.1007/s00467-011-2037-0. Epub 2012 Jan 3.
5
Long-term renal outcomes of APRT deficiency presenting in childhood.
Pediatr Nephrol. 2019 Mar;34(3):435-442. doi: 10.1007/s00467-018-4109-x. Epub 2018 Nov 15.
7
Renal stones in two children with two rare etiologies.
Saudi J Kidney Dis Transpl. 2018 Sep-Oct;29(5):1203-1206. doi: 10.4103/1319-2442.243955.
8
2,8-Dihydroxyadenine Nephropathy Identified as Cause of End-Stage Renal Disease After Renal Transplant.
Exp Clin Transplant. 2017 Oct;15(5):574-577. doi: 10.6002/ect.2015.0096. Epub 2015 Aug 31.

引用本文的文献

1
A case of 2,8-DHA crystalline nephropathy caused by adenine phosphoribosyltransferase deficiency: diagnosis and treatment.
CEN Case Rep. 2023 Aug;12(3):329-334. doi: 10.1007/s13730-022-00768-1. Epub 2022 Dec 28.

本文引用的文献

2
Genetic defects underlying renal stone disease.
Int J Surg. 2016 Dec;36(Pt D):590-595. doi: 10.1016/j.ijsu.2016.11.015. Epub 2016 Nov 10.
3
Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency.
J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Nov 15;1036-1037:170-177. doi: 10.1016/j.jchromb.2016.09.018. Epub 2016 Sep 14.
4
Kidney Disease in Adenine Phosphoribosyltransferase Deficiency.
Am J Kidney Dis. 2016 Mar;67(3):431-8. doi: 10.1053/j.ajkd.2015.10.023. Epub 2015 Dec 25.
5
Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.
Can J Kidney Health Dis. 2015 Sep 15;2:31. doi: 10.1186/s40697-015-0069-2. eCollection 2015.
7
Recurrent 2,8-dihydroxyadenine nephropathy: a rare but preventable cause of renal allograft failure.
Am J Transplant. 2014 Nov;14(11):2623-32. doi: 10.1111/ajt.12926. Epub 2014 Oct 10.
8
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
J Am Soc Nephrol. 2015 Mar;26(3):543-51. doi: 10.1681/ASN.2014040388. Epub 2014 Oct 8.
9
2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism.
Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):241-52. doi: 10.1080/15257770.2013.853780.
10
Febuxostat in adenosine phosphoribosyltransferase deficiency.
Am J Kidney Dis. 2014 Aug;64(2):316. doi: 10.1053/j.ajkd.2014.04.026. Epub 2014 Jun 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验